On March 24, 2026, eight insiders at Surrozen, Inc./DE (SRZN) executed significant share purchases totaling approximately $10.53 million. The transactions involved multiple entities associated with TCG Crossover, including Crossover Fund Iii, L.P., Crossover Fund Ii, L.P., Crossover Gp Ii, Llc, and Crossover Gp Iii, Llc. Each of these entities acquired 53,329 shares at a price of $24.69 per share, resulting in individual transactions valued at $1.32 million.
This coordinated buying activity among multiple insiders is often viewed as a strong bullish indicator, suggesting a collective confidence in the company's future prospects. The scale of the investment indicates a substantial commitment from these individuals and entities.
Surrozen, Inc. operates in the biotechnology sector, focusing on developing therapeutics. The recent insider purchases occur amidst ongoing developments in the pharmaceutical and biotechnology industries.